Here are seven biopharma-related trends for 2026 that have emerged from GEN interviews with experts and other industry stakeholders, and from reviews of reports and public statements.

Scientists at Duke-NUS Medical School have developed two powerful computational tools that could transform how researchers ...

The diagnostic armamentarium for solid tumors is evolving rapidly, redefining how we detect, stage, stratify, monitor, and ultimately treat cancer. This ...